Papadakis, V <br/><br/>
High-dose carmustine, thiotepa and etoposide followed by autologous bone marrow rescue for the treatment of high risk central nervous system tumors.  [electronic resource] 

 -  Bone marrow transplantation  Jul 2000 
 - 153-60 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0268-3369 
<br/><br/><label>Standard No.: </label>10.1038/sj.bmt.1702475  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Bone Marrow Transplantation<br/>Carmustine--administration & dosage<br/>Central Nervous System Neoplasms--complications<br/>Chemical and Drug Induced Liver Injury<br/>Child<br/>Child, Preschool<br/>Combined Modality Therapy<br/>Disease-Free Survival<br/>Etoposide--administration & dosage<br/>Female<br/>Graft Survival<br/>Hematologic Diseases--chemically induced<br/>Humans<br/>Infant<br/>Kidney Diseases--chemically induced<br/>Lung Diseases--chemically induced<br/>Male<br/>Middle Aged<br/>Multiple Organ Failure--chemically induced<br/>Nervous System Diseases--chemically induced<br/>Survival Rate<br/>Thiotepa--administration & dosage<br/>Transplantation, Autologous<br/>Treatment Outcome